OUR PRODUCTS

MOBILE APPS

GENERAL INFO

XERS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Xeris Biopharma Holdings (XERS) Earnings Date & Reports

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

XERS is expected to report earnings to fall 80.00% to 0 cents per share on November 06

Xeris Biopharma Holdings XERS Stock Earnings Reports

Q3'25

Est.

$0.00

Q2'25

Beat

by $0.02

Q1'25

Missed

by $0.01

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.02

The last earnings report on August 07 showed earnings per share of 0 cents, beating the estimate of -2 cents. With 1.67M shares outstanding, the current market capitalization sits at 1.10B.

View a ticker or compare two or three

Compare

XERS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For XERS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. XERS showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of ready-to-use, liquid-stable injectables

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

1375 West Fulton Street

Phone

+1 844 445-5704

Employees

377

Web

https://www.xerispharma.com